Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s):  QNTM

Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.


CSE:QNTM - Post by User

Post by DavidRosenbergon Mar 13, 2023 7:22pm
63 Views
Post# 35336284

Volatility during recession

Volatility during recession
Markets can be volatile during a recession for several reasons:
 
Uncertainty: During a recession, there is often a high degree of uncertainty about the future state of the economy. Investors may be uncertain about the length and severity of the recession, as well as the government's response to it. This uncertainty can lead to increased volatility in the markets as investors adjust their expectations and react to new information.
Investor sentiment: During a recession, investor sentiment can be negative, leading to increased selling pressure on stocks. This negative sentiment can be driven by fears of job losses, lower consumer spending, and reduced corporate profits.
 
Credit risk: In a recession, companies may be more likely to default on their debts, which can increase credit risk and cause investors to become more risk-averse. This can lead to increased volatility as investors shift their money out of riskier assets, such as stocks, and into safer assets, such as government bonds.
Economic indicators: Economic indicators, such as GDP growth, unemployment rates, and consumer spending, can have a significant impact on market volatility during a recession. Negative economic indicators can lead to increased volatility as investors adjust their expectations for corporate profits and growth.
 
Overall, the combination of uncertainty, negative sentiment, credit risk, and economic indicators can create a volatile environment for the markets during a recession. However, it's important to remember that not all recessions are the same, and the specific factors driving market volatility can vary depending on the circumstances.
<< Previous
Bullboard Posts
Next >>